CLBAX
Price
$40.32
Change
+$0.07 (+0.17%)
Updated
Jul 31 closing price
Net Assets
288.09B
WBCCX
Price
$10.11
Change
+$0.04 (+0.40%)
Updated
Jul 31 closing price
Net Assets
30.78M
Interact to see
Advertisement

CLBAX vs WBCCX

CLBAX vs WBCCX Comparison Chart in %
View a ticker or compare two or three
VS
CLBAX vs. WBCCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Buy and WBCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 288B vs. WBCCX (30.8M). CLBAX pays higher dividends than WBCCX: CLBAX (1.82) vs WBCCX (0.23). CLBAX was incepted earlier than WBCCX: CLBAX (24 years) vs WBCCX (25 years). WBCCX (2.18) is less costly to investors than CLBAX (0.58). WBCCX is a more actively managed with annual turnover of: 77.00 vs. CLBAX (50.00). CLBAX has a lower initial minimum investment than WBCCX: CLBAX (250) vs WBCCX (1000). CLBAX annual gain was more profitable for investors over the last year : 11.32 vs. WBCCX (-4.75). CLBAX return over 5 years is better than : 34.10 vs. WBCCX (-18.14).
CLBAXWBCCXCLBAX / WBCCX
Total Expense Ratio0.582.1827%
Annual Report Gross Expense Ratio0.582.1827%
Fund Existence24 years25 years-
Gain YTD8.4044.727178%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B30.8M935,065%
Annual Yield % from dividends1.820.23801%
Returns for 1 year11.32-4.75-239%
Returns for 3 years38.621.682,301%
Returns for 5 years34.10-18.14-188%
Returns for 10 years93.45-13.33-701%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PLBEX34.870.45
+1.31%
Plumb Equity Investor
JHACX10.170.01
+0.10%
JHancock Multi-Asset Absolute Return C
HNIDX16.30-0.11
-0.67%
Harbor Diversified Intl All Cp Retire
ERSMX29.37-0.20
-0.68%
Eaton Vance Atlanta Capital SMID-Cap R
FBTIX49.83-1.21
-2.37%
Fidelity Advisor Biotechnology I